Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
In March, the RESILIENCE project passed the halfway point of its recruitment process, with more than 300 people participating in this clinical trial, which aims to reduce the incidence of heart failure in cancer survivors. Patients are distributed among the 22 hospitals in the six countries participating in this multinational project funded by the European […]
